Cas:850568-56-8 (4-butan-2-ylphenyl)boronic acid manufacturer & supplier

Chemical Name:(4-butan-2-ylphenyl)boronic acid

CAS.NO:850568-56-8

Synonyms:4-sec-butylphenylboronic acid

Molecular Formula:C₁₀H₁₅BO₂

Molecular Weight:178.03600

HS Code:2931900090

Physical and Chemical Properties:

Melting point:96-100ºC

Boiling point:301.2ºC at 760 mmHg

Density:1.02g/cm3

Index of Refraction:1.509

PSA:40.46000

Exact Mass:178.11700

LogP:0.87990

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-sec-butylphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-sec-butylphenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-sec-butylphenylboronic acid Use and application,4-sec-butylphenylboronic acid technical grade,usp/ep/jp grade.

Related News: This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. (4-butan-2-ylphenyl)boronic acid manufacturer The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. (4-butan-2-ylphenyl)boronic acid supplier The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. (4-butan-2-ylphenyl)boronic acid vendor In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation. (4-butan-2-ylphenyl)boronic acid factory Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.